Derivation and Characterization of Mesenchymal Stem Cells from iPS Cells. Chapter uri icon


  • Mesenchymal stem/stromal cells (MSCs) show excellent therapeutic potentials in many preclinical studies and clinical trials. However, the clinical application of conventional tissue-derived MSCs faces challenges of limited scalability and high donor variations. To address these challenges, we established a protocol for deriving and characterizing MSCs from human induced pluripotent stem cells (iPSCs) with a theoretically limitless expandability. The iPSC-MSCs show biological properties comparable to or better than early passage bone marrow MSCs and can be scaled up to huge amounts with uniform properties.

author list (cited authors)

  • Zhao, Q., & Liu, F.

citation count

  • 2

complete list of authors

  • Zhao, Qingguo||Liu, Fei

Book Title

  • Induced Pluripotent Stem (iPS) Cells

publication date

  • January 2022